Zobrazeno 1 - 10
of 1 222
pro vyhledávání: '"Inactivated poliovirus vaccine"'
Autor:
Yan Xu, Haiping Chen, Binbing Wang, Xiaoping Zhu, Linyun Luo, Shengyi Wang, Yanhui Xiao, Hui Wang, Rui Ma, Shaoxiang Liu, Long Yan, Xiuling Li, Dandan Chen, Ying Su, Yu chai, Jun Fu, Xiaoying Mao, Jie Cao, Pufei Sun, Fenyang Tang, Xiang Sun, Zhiguo Wang, Xiaoming Yang
Publikováno v:
International Journal of Infectious Diseases, Vol 137, Iss , Pp 9-15 (2023)
Objectives: During the COVID-19 pandemic, there was a decline in vaccine coverage, and the implementation of combined vaccines and co-administration strategies emerged as potential solutions to alleviate this predicament. Our objective is to delve in
Externí odkaz:
https://doaj.org/article/8cd8799451dd4183bf3e89691f94bdb4
Autor:
Guangwei Feng, Deyu Jiang, Weixiao Han, Zhiqiang Xie, Zhiwei Jiang, Lili Huang, Jianfeng Wang, Wei Zhang, Li Xu, Jiebing Tan, Wangyang You, Guoliang Cui, Changgui Li, Yanxia Wang
Publikováno v:
International Journal of Infectious Diseases, Vol 130, Iss , Pp 20-27 (2023)
ABSTRACT: Objectives: To evaluate the safety, immunogenicity, and lot-to-lot consistency of Sabin strain-based inactivated polio vaccine (sIPV) in a five-dose vial presentation. Methods: Stage I was an open-label safety observation, in which 72 healt
Externí odkaz:
https://doaj.org/article/d0be7cecfa744464b5969ca6aebff923
Autor:
Lalitendu Mohanty, T. Jacob John, Shailesh D. Pawar, Padmasani Venkat Ramanan, Sharad Agarkhedkar, Pradeep Haldar
Publikováno v:
Vaccines, Vol 12, Iss 4, p 424 (2024)
Background: In 2016, the Global Polio Eradication Initiative (GPEI) recommended the cessation of using type 2 oral poliovirus vaccine (OPV) and OPV, with countries having to switch from the trivalent to bivalent OPV (bOPV) with the addition of inacti
Externí odkaz:
https://doaj.org/article/8c70d2cdfd5c4563ae379bc9ebf3b422
Publikováno v:
Pathogens, Vol 13, Iss 3, p 224 (2024)
Inactivated poliovirus vaccine (IPV), available since 1955, became the first vaccine to be used to protect against poliomyelitis. While the immunogenicity of IPV to prevent paralytic poliomyelitis continues to be irrefutable, its requirement for stro
Externí odkaz:
https://doaj.org/article/5de9c4aeb60041ad9a9295b459e6af65
Autor:
Lei Ma, Zhifang Ying, Wei Cai, Jianfeng Wang, Jian Zhou, Huijuan Yang, Jingxia Gao, Zhimei Zhao, Jing Liu, Shengjie Ouyang, Shaohui Song, Fei Shen, Ruirui Zhao, Lilan Xu, Xiaohu Dai, Yanan Wu, Weidong Li, Changgui Li, Guoyang Liao
Publikováno v:
EClinicalMedicine, Vol 64, Iss , Pp 102151- (2023)
Summary: Background: In a previous phase 3 clinical trial, we showed that an inactivated poliovirus vaccine derived from the Sabin strain (sIPV) can induce neutralising antibodies against currently circulating and reference wild poliovirus strains. H
Externí odkaz:
https://doaj.org/article/c49a7d2187674c80b3ef8ed9e887b63d
Autor:
A. N. Piniaeva, A. A. Kovpak, Y. Y. Ivin, S. H. Sandzhieva, A. A. Shishova, I. O. Tсelykh, V. E. Vasilenko, K. V. Kaa, Zh. H. Mazhed, Yu. Kh. Khapchaev, A. A. Siniugina, A. A. Ishmukhametov
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 21, Iss 5, Pp 107-119 (2022)
Relevance. The production and quality control of any drugs are strictly regulated. In the case of antiviral vaccines, the requirements for their safety and protective activity are getting tougher every year. Vaccine manufacturers face three tasks: en
Externí odkaz:
https://doaj.org/article/ec8ee23723754b3b90aea36419e76609
Autor:
Qiongzhou Yin, Yan Zheng, Zhifang Ying, Jingyu Li, Ya Jiang, Wenmei Bao, Youjian Dou, Yi Pu, Jin Lei, Haitao Yang, Ruiju Jiang, Yan Deng, Zhimei Zhao, Jing Pu, Jing Yang, Yadong Li, Min Xu, Wei Cai, Yanchun Che, Li Shi
Publikováno v:
Vaccines, Vol 12, Iss 2, p 217 (2024)
Background: An inactivated poliomyelitis vaccine made from Sabin strains (sIPVs) has widely been used in China since 2015. However, the quantitative data on the instant and persistent inhibition effects of maternal poliovirus antibodies on the immune
Externí odkaz:
https://doaj.org/article/9f0bacde7e3b4faaa5c55e5976696f11
Autor:
Guangwei Feng, Ming Shao, Jianfeng Wang, Lili Huang, Jian Tan, Zhiwei Jiang, Wangyang You, Yurong Li, Yonghui Yang, Jing Li, Yanxia Wang
Publikováno v:
Vaccines, Vol 12, Iss 2, p 123 (2024)
Background: The multidose Sabin-strain inactivated poliovirus vaccine (sIPV) has the potential to significantly aid in the eradication of poliomyelitis, particularly in low- and middle-income countries. As part of a phase III clinical trial in which
Externí odkaz:
https://doaj.org/article/1d3d6db04e6f455ba96f2b2c78d08b12
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.